
Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium
2026-05-31
0:00
39:56
Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.
Fler avsnitt från "Deep Margin"



Missa inte ett avsnitt av “Deep Margin” och prenumerera på det i GetPodcast-appen.








